Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis

BACKGROUND: Linezolid, which has bacteriostatic activity, is approved for the treatment of vancomycin-resistant enterococci (VRE) infections. Meanwhile, daptomycin exerts bactericidal activity against VRE, but is not approved for the treatment of VRE bacteremia. Only a few studies with small sample...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuang, Yu-Chung, Wang, Jann-Tay, Lin, Hsin-Yi, Chang, Shan-Chwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269951/
https://www.ncbi.nlm.nih.gov/pubmed/25495779
http://dx.doi.org/10.1186/s12879-014-0687-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269951/
https://www.ncbi.nlm.nih.gov/pubmed/25495779
http://dx.doi.org/10.1186/s12879-014-0687-9

Ejemplares similares